2025 · 4th Quarter (Oct 1 - Dec 31)
Filed by THE NICKLES GROUP, LLC.
Open official filingSource-reported fields
Literal source text
Implementation of drug pricing provisions related to H.R. 5376 (P.L. 117-169), The Inflation Reduction Act. Issues related to safe mobility. Issues related to reimbursement for breakthrough devices. Issues related to payment for prescription drugs. Issues concerning drug shortages. Issues related to extension of the hospital at home program.
Literal federal measure citations: H.R. 5376
Monitored implementation of H.R. 1 (P.L. 119-21), One Big Beautiful Bill Act, as it relates to corporate taxes.
Literal federal measure citations: H.R. 1
Monitored issues related to pharmaceutical prices. Issues regarding the pharmaceutical and medical device supply chain. Monitored issues concerning drug shortages. Issues concerning the reauthorization of Pandemic and All-Hazards Preparedness and Response Act (PAHPA). Monitored AI issues. Monitored cybersecurity issues. Issues concerning emergency preparedness and critical medical supplies. Issues concerning regulatory reforms.
Issues related to tariffs.
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
